Recent Settlements | Actos Lawsuit

Drugmakers Seek Reversal of $9 Billion Actos Bladder Cancer Lawsuit Verdict

Laura Woods | July 15th, 2014
Actos courthouse

Takeda Pharmaceuticals and Eli Lilly are seeking to have a $9 billion Actos bladder cancer lawsuit verdict reversed or for a new trial. The companies claim the jury awarded the momentous verdict out of “passion and prejudice.” A Louisiana federal jury hit the pharmaceutical giants with an overwhelming $9 billion in punitive damages and an additional $1.5 million in compensatory… Read more »

Illinois Actos Verdict Favors Takeda

Laura Woods | June 3rd, 2014
Actos courthouse

An Illinois state court jury recently returned an Actos verdict in favor of Takeda, claiming Japanese-based drug maker wasn’t responsible for the bladder cancer death of an Illinois man. While the trial lasted more than four weeks, jurors took less than two hours to deliberate before returning a verdict. William Whitlach, the late husband of plaintiff Diane Whitlach, died from… Read more »

Jury Finds for Defense in Las Vegas Actos Trial

Jacky Gale | May 29th, 2014
Old Woman Thumbnail 6

On May 22, 2014, the jury in a Las Vegas Actos trial that has garnered nationwide attention found for the defendants, Takeda Pharmaceuticals. The ruling shocked the plaintiffs, 81-year-old Delores Cipriano and 80-year-old Bertha Triana, who consolidated their lawsuits against the pharmaceutical giant because they shared allegations that the drug Actos caused their bladder cancer. Actos is a medication prescribed… Read more »

First Federal Actos Cancer Trial Being Tried in Louisiana

Steve Cid | March 14th, 2014
Courthose Thumbnail 3

The first federal Actos bladder cancer lawsuit to go before a jury began on February 3rd, 2014 in US District Court, Western Louisiana. The suit was brought by Terrance Allen, a former hardware store manager and user of the diabetes drug, Actos, against the manufacturer, Takeda Pharmaceuticals, Asia’s largest drugmaker. The suit alleges that Takeda willfully hid the cancer risks… Read more »

Jury Finds Takeda Failed to Warn About Actos Bladder Cancer Risk

Sarah Klein | October 9th, 2013
Courthose Thumbnail 2

A jury ruled that Takeda Pharmaceuticals failed to warn a deceased Maryland man about the risk that Actos, a diabetes drug, could cause bladder cancer.  They awarded the man’s family more than $1.7 million in damages late last month, but the judge immediately threw out the verdict.  This Actos bladder cancer lawsuit is one of 3,000 currently pending against the… Read more »